Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Brain tissue salvage in acute stroke.

Perttu J Lindsberg1

  • 1Department of Neurology, Helsinki University Central Hospital, Helsinki. perttu.lindsberg@hus.fi

Neurocritical Care
|September 22, 2005
PubMed
Summary

Thrombolysis is the primary treatment for acute ischemic stroke within 3 hours. Neuroprotective strategies are less effective, but advanced imaging may expand treatment windows for salvaging brain tissue.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical utility of measuring circulating glial fibrillary acidic protein in severe stroke.

Stroke and vascular neurology·2025
Same author

Intravenous thrombolysis versus endovascular thrombectomy in acute basilar artery occlusion-A multicenter cohort study.

International journal of stroke : official journal of the International Stroke Society·2025
Same author

Carotid endarterectomy and the risk of perioperative stroke: The importance of chronic ischaemic lesions and small vessel disease.

European journal of neurology·2025
Same author

Long-term cognitive and neurovascular changes after carotid endarterectomy.

Journal of the neurological sciences·2024
Same author

IV Thrombolysis in Basilar Artery Occlusion: Outcomes and Comparison With Endovascular Thrombectomy.

Neurology·2024
Same author

MANF protein expression is upregulated in immune cells in the ischemic human brain and systemic recombinant MANF delivery in rat ischemic stroke model demonstrates anti-inflammatory effects.

Acta neuropathologica communications·2024

Area of Science:

  • Neurology
  • Emergency Medicine
  • Pharmacology

Background:

  • Thrombolysis is the sole effective medical therapy for ultra-acute cerebral ischemia.
  • Neuroprotective strategies have shown limited success in salvaging brain cells.
  • Current treatment is typically limited to a 3-hour window post-stroke.

Purpose of the Study:

  • To review the potential for salvaging acutely ischemic brain tissue.
  • To explore reasons for differing efficacies between thrombolytic and neuroprotective therapies.
  • To discuss advancements in imaging and patient selection for expanded treatment.

Main Methods:

  • Review of existing clinical and experimental research on thrombolysis and neuroprotection.
  • Analysis of imaging techniques for identifying viable brain tissue (penumbra).
  • Evaluation of patient selection criteria for acute ischemic stroke treatment.

Main Results:

  • Thrombolysis is established as effective in the early phase of ischemic stroke.
  • Neuroprotection has not yet demonstrated significant clinical efficacy.
  • Advancements in imaging may allow for identification of salvageable tissue beyond the traditional 3-hour window.

Conclusions:

  • Thrombolysis remains the cornerstone of acute ischemic stroke treatment within the established time frame.
  • Further research is needed to improve the efficacy of neuroprotective agents.
  • Improved patient selection via advanced imaging holds promise for extending therapeutic opportunities in ischemic stroke.

Related Experiment Videos